Virginia Hemp THC Cap: Regulations, Legal Challenges, and Industry Impact

Executive Summary

Virginia's new hemp THC cap, which restricts total THC content in hemp products to 0.3% by dry weight, has triggered a federal lawsuit from hemp businesses seeking to block the regulation before it takes effect. The policy represents one of the most restrictive interpretations of hemp law in the United States, fundamentally reshaping the state's previously permissive approach to hemp-derived cannabinoid products. Filed in federal district court in August 2026, the lawsuit argues that Virginia's cap conflicts with federal hemp definitions under the 2018 Farm Bill and violates constitutional protections. The regulation threatens to eliminate an estimated $300-500 million hemp-derived cannabinoid market in Virginia, affecting hundreds of retailers, manufacturers, and thousands of jobs. At stake is not only Virginia's hemp industry but also the broader question of state authority to regulate federally legal hemp products—a tension playing out across multiple states as lawmakers grapple with the proliferation of intoxicating hemp-derived products like delta-8 THC, THCA flower, and high-potency edibles.

Why This Matters

Virginia's THC cap affects thousands of businesses, millions of consumers, and sets a precedent that could reshape hemp regulation nationwide. The economic impact extends across Virginia's entire hemp supply chain. According to industry estimates, the commonwealth hosts approximately 800-1,200 retail locations selling hemp-derived products, from dedicated smoke shops to convenience stores and wellness boutiques. These businesses collectively employ an estimated 5,000-8,000 workers directly, with thousands more in ancillary services including testing laboratories, packaging suppliers, and distribution networks. For consumers, the regulation effectively eliminates access to popular hemp-derived products that have filled the gap left by Virginia's limited adult-use cannabis program. An estimated 200,000-400,000 Virginia residents regularly purchase hemp-derived cannabinoid products, many seeking alternatives to pharmaceutical medications for conditions including chronic pain, anxiety, insomnia, and inflammation. Unlike the state's tightly controlled medical cannabis program, hemp products have been widely accessible without physician authorization or state registration. The legal implications extend beyond Virginia. At least 15 states are currently considering or have implemented similar THC caps on hemp products, watching Virginia's litigation closely. The case tests fundamental questions about federalism and the scope of the 2018 Farm Bill's preemption of state hemp regulation. A ruling favoring Virginia could embolden other states to impose restrictive caps; a decision blocking the regulation could constrain state authority to address intoxicating hemp products. Investors and multi-state operators have particular stakes in the outcome. Major hemp companies including Charlotte's Web, cbdMD, and numerous regional processors have Virginia operations or distribution networks that would face immediate disruption. The uncertainty has already frozen capital investment in Virginia hemp infrastructure, with several planned processing facilities and retail expansions on hold pending resolution.

Background and History

Virginia's journey from hemp pioneer to restrictive regulator reflects the national tension between the 2018 Farm Bill's hemp legalization and states' efforts to control intoxicating cannabinoid products.

The 2018 Farm Bill Foundation

The Agricultural Improvement Act of 2018, commonly known as the 2018 Farm Bill, removed hemp from Schedule I of the Controlled Substances Act, defining hemp as cannabis containing no more than 0.3% delta-9 THC on a dry weight basis. This definition, codified at 7 U.S.C. § 1639o, created a legal distinction between marijuana (cannabis above 0.3% delta-9 THC) and hemp (cannabis at or below that threshold). The legislation explicitly preserved state authority to regulate hemp production and commerce within their borders, setting up the current federalism conflict. Virginia moved quickly to capitalize on federal hemp legalization. In 2019, the General Assembly passed comprehensive hemp legislation establishing a regulatory framework administered by the Virginia Department of Agriculture and Consumer Services (VDACS). The state's program, approved by the USDA in 2020, focused primarily on agricultural hemp cultivation for fiber, grain, and CBD extraction.

The Delta-8 THC Explosion (2020-2022)

The hemp market transformed dramatically in 2020 with the emergence of delta-8 THC, a psychoactive cannabinoid that can be synthesized from CBD through chemical conversion. Unlike delta-9 THC (the primary intoxicating compound in marijuana), delta-8 THC exists naturally in cannabis only in trace amounts. However, manufacturers discovered they could convert abundant, inexpensive CBD from hemp into delta-8 THC through isomerization processes. By late 2021, Virginia hosted an estimated 400-600 retailers selling delta-8 THC products, with virtually no regulatory oversight beyond basic hemp compliance. Products ranged from vape cartridges and gummies to tinctures and flower sprayed with delta-8 distillate. The market operated in a regulatory gray zone: technically legal under federal hemp law (since the products derived from compliant hemp and contained less than 0.3% delta-9 THC), but clearly intoxicating and unregulated.

THCA Flower and the Loophole Expansion (2022-2024)

The market evolved again with the proliferation of THCA flower—cannabis flower that is chemically identical to marijuana but tests below 0.3% delta-9 THC because THCA (the acidic precursor to delta-9 THC) is not included in the legal definition. When heated through smoking or vaporization, THCA converts to delta-9 THC, producing effects indistinguishable from marijuana. Virginia retailers openly sold THCA flower by 2023, marketing it as "legal weed" and "hemp flower." The products came from cultivators in states including Oregon, Oklahoma, and North Carolina, who carefully harvested cannabis at the precise moment when THCA content was high but delta-9 THC remained below the 0.3% threshold. Testing protocols that measured only delta-9 THC—as required by federal hemp regulations—classified these products as legal hemp despite their obvious intoxicating potential.

Legislative Response and Industry Pushback (2024-2025)

The Virginia General Assembly first attempted to address intoxicating hemp products in the 2024 legislative session. House Bill 1445 proposed restricting hemp-derived cannabinoid products to 2 mg of total THC per serving and 10 mg per package. The bill passed the House but died in the Senate Agriculture, Conservation and Natural Resources Committee after intensive lobbying from hemp industry groups including the Virginia Hemp Coalition and the U.S. Hemp Roundtable. Regulatory efforts continued outside the legislature. In September 2024, VDACS issued guidance suggesting that products containing intoxicating amounts of any THC isomer might violate Virginia's hemp statute. The guidance lacked enforcement mechanisms and was largely ignored by retailers. The breakthrough came in the 2025 General Assembly session. Senate Bill 903, sponsored by Senator Emmett Hanger, proposed a total THC cap of 0.3% by dry weight—meaning all THC isomers combined, not just delta-9 THC. The bill explicitly defined "total THC" to include delta-8 THC, delta-10 THC, THCA, and other THC analogs. After contentious committee hearings featuring testimony from hemp businesses, law enforcement, public health advocates, and cannabis industry representatives, the bill passed both chambers with amendments.

Governor's Signature and Implementation Timeline (2025-2026)

Governor Glenn Youngkin signed SB 903 into law on April 15, 2025, with an effective date of July 1, 2026. The legislation gave businesses a 15-month runway to comply, sell through existing inventory, and adjust business models. VDACS received authority to enforce the cap through inspections, product testing, and administrative penalties including fines up to $10,000 per violation and license revocation. The implementation period saw intense industry activity. Some businesses began liquidating inventory through aggressive sales and promotions. Others pivoted toward compliant CBD products or prepared to exit the Virginia market entirely. A coalition of hemp businesses, including retailers, manufacturers, and trade associations, began organizing legal challenges. On June 15, 2026, VDACS published final regulations implementing the THC cap, including testing protocols, labeling requirements, and enforcement procedures. The regulations specified that total THC would be calculated as delta-9 THC plus (THCA × 0.877), the standard conversion factor accounting for the molecular weight difference between THCA and delta-9 THC.

Federal Lawsuit Filed (August 2026)

On August 8, 2026, a coalition of Virginia hemp businesses filed suit in the U.S. District Court for the Eastern District of Virginia, seeking a preliminary injunction to block the THC cap before its July 1 effective date. The plaintiffs include retail stores, product manufacturers, and the Virginia Hemp Trade Association. The lawsuit names VDACS Commissioner Brad Copenhaver and Attorney General Jason Miyares as defendants.

Key Players

Virginia Department of Agriculture and Consumer Services (VDACS)

VDACS serves as the primary regulatory authority for hemp in Virginia, administering the state's USDA-approved hemp program. The agency oversees hemp cultivation licensing, conducts compliance testing, and now bears responsibility for enforcing the THC cap. Commissioner Brad Copenhaver has defended the regulation as necessary to protect public health and distinguish legal hemp from intoxicating marijuana products. VDACS has allocated approximately $2.5 million for THC cap enforcement, including hiring additional inspectors and expanding laboratory testing capacity.

Virginia General Assembly

The legislature drove the policy change through SB 903. Senator Emmett Hanger, the bill's chief patron, represents a rural district with significant agricultural interests and has expressed concern about unregulated intoxicating products marketed to youth. Delegate Terry Kilgore co-patroned companion legislation in the House. The bill received bipartisan support, passing the Senate 28-12 and the House 64-34, reflecting broad concern about hemp-derived intoxicating products despite opposition from libertarian-leaning legislators.

Hemp Industry Coalition

The plaintiff coalition includes diverse businesses across Virginia's hemp supply chain. Lead plaintiffs include Green Leaf Wellness (a Richmond-based chain with seven locations), Commonwealth Extracts (a processor in Roanoke), and the Virginia Hemp Trade Association (representing approximately 200 businesses). Legal representation comes from Troutman Pepper Hamilton Sanders LLP, a national firm with extensive cannabis and hemp regulatory experience. The coalition has raised approximately $500,000 for litigation costs through member contributions and crowdfunding.

Virginia Cannabis Control Authority

The state's cannabis regulatory body has maintained a careful distance from the hemp THC cap debate, focusing on its mandate to implement Virginia's limited adult-use cannabis program. However, the authority has a vested interest in the outcome: eliminating competing hemp products could drive consumers toward licensed cannabis dispensaries, though Virginia's program remains limited with only a handful of operational retail locations as of 2026.

Public Health and Law Enforcement Advocates

The Virginia Association of Chiefs of Police supported the THC cap, citing concerns about impaired driving and the difficulty of distinguishing legal hemp from illegal marijuana in field tests. The Virginia Department of Health provided testimony during legislative hearings highlighting emergency department visits related to high-potency hemp products, particularly among adolescents consuming delta-8 THC edibles. These groups argue the cap restores clarity to hemp regulation and protects vulnerable populations.

National Hemp Organizations

The U.S. Hemp Roundtable and the National Hemp Association have filed amicus briefs supporting the Virginia plaintiffs, arguing that restrictive state THC caps threaten the national hemp industry and contradict congressional intent in the 2018 Farm Bill. These organizations represent thousands of hemp businesses nationwide and have coordinated legal strategies across multiple state challenges.

Legal and Regulatory Framework

The Virginia hemp THC cap lawsuit centers on conflicts between federal hemp law, state regulatory authority, and constitutional protections for interstate commerce.

Federal Hemp Law: The 2018 Farm Bill

The Agricultural Improvement Act of 2018 defines hemp at 7 U.S.C. § 1639o as "the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis." This definition is critical: it specifies delta-9 THC only, not total THC, and applies to the plant material itself. The statute explicitly preserves state authority at 7 U.S.C. § 1639p, stating "Nothing in this section preempts or limits any law of a State or Indian Tribe that regulates the production of hemp" and allows states to be "more stringent" than federal requirements. However, the scope of this state authority—particularly whether it extends to finished hemp products versus agricultural production—remains legally contested.

Virginia's Hemp Statute and THC Cap

Virginia Code § 3.2-4112 et seq. establishes the commonwealth's hemp program. Senate Bill 903 amended § 3.2-4150 to add: "No person shall manufacture, distribute, sell, or offer for sale any hemp product containing a total tetrahydrocannabinol concentration exceeding 0.3 percent on a dry weight basis." The statute defines "total tetrahydrocannabinol" to include "all tetrahydrocannabinol isomers, acids, salts, and salts of isomers, including but not limited to delta-8-tetrahydrocannabinol, delta-10-tetrahydrocannabinol, and tetrahydrocannabinolic acid (THCA)." The law includes limited exceptions for hemp products in transit through Virginia and for industrial hemp materials not intended for human consumption. Penalties escalate from civil fines for first violations to potential criminal misdemeanor charges for knowing, repeated violations.

Plaintiff Legal Arguments

The hemp industry lawsuit advances four primary legal theories: **Federal Preemption**: Plaintiffs argue that the 2018 Farm Bill established a uniform federal definition of hemp that preempts conflicting state definitions. They contend that Virginia's total THC cap effectively redefines hemp in a manner inconsistent with federal law, creating an impermissible conflict. The complaint cites the Supremacy Clause (U.S. Constitution, Article VI, Clause 2) and argues that Congress intended to create a national hemp market with consistent standards. **Dormant Commerce Clause**: The lawsuit alleges that Virginia's THC cap discriminates against interstate commerce by effectively banning hemp products legally produced in other states under federal law. Because hemp cultivation and processing occur nationally, with products crossing state lines, Virginia's restriction imposes an undue burden on interstate commerce without adequate local justification. The complaint cites precedent from *Pike v. Bruce Church, Inc.*, 397 U.S. 137 (1970). **Void for Vagueness**: Plaintiffs argue that the total THC definition is unconstitutionally vague because it fails to provide clear notice of what products are prohibited. The complaint notes that naturally occurring THC isomers exist in trace amounts in all cannabis plants, potentially making any hemp product non-compliant depending on testing sensitivity and methodology. **Arbitrary and Capricious**: Under the Administrative Procedure Act framework, plaintiffs contend that VDACS's implementation regulations are arbitrary because they lack scientific justification for the 0.3% total THC threshold and fail to account for natural variation in hemp cannabinoid profiles.

State Defense Arguments

Virginia's defense, articulated in preliminary court filings, rests on several counterarguments: **State Police Powers**: The commonwealth asserts broad authority under the Tenth Amendment to regulate substances within its borders to protect public health and safety. The state argues that intoxicating hemp products present the same risks as marijuana and fall within traditional state regulatory domains. **Savings Clause Interpretation**: Virginia contends that the 2018 Farm Bill's explicit preservation of state authority to be "more stringent" encompasses total THC caps on finished products, not just agricultural hemp production standards. **No Conflict with Federal Law**: The state argues there is no actual conflict because Virginia's law does not prohibit anything federal law requires—it merely restricts certain products within state borders while leaving federally compliant hemp legal. **Rational Basis**: Virginia asserts that the THC cap serves legitimate governmental interests in preventing youth access to intoxicating substances, reducing impaired driving, and maintaining clear legal distinctions between hemp and marijuana.

State-by-State Breakdown of Hemp THC Caps

At least 12 states have enacted or proposed restrictions on total THC in hemp products, creating a patchwork regulatory landscape that challenges interstate commerce.

States with Total THC Caps Enacted

State	Total THC Limit	Effective Date	Key Provisions
Virginia	0.3% total THC	July 1, 2026	Includes all THC isomers; VDACS enforcement
Oregon	0.3% total THC	June 2023	Applies to ingestible products only; smokable hemp flower exempt
Minnesota	5 mg per serving, 50 mg per package	July 2023	Edibles only; age-restricted sales required
Colorado	0.3% total THC	January 2024	Converted THCA included; medical exemptions available
Montana	0.3% total THC	October 2023	Broad ban on intoxicating hemp products

California

California has not enacted a statewide total THC cap, but Assembly Bill 45 (2023) established regulatory authority for the Department of Cannabis Control to oversee hemp products containing any amount of THC. The state requires hemp products with detectable THC to be sold only through licensed cannabis retailers, effectively creating a regulatory pathway rather than an outright ban. This approach has generated approximately $15-20 million in additional cannabis tax revenue while preserving consumer access.

New York

New York's Office of Cannabis Management issued emergency regulations in September 2023 restricting hemp-derived cannabinoid products to licensed cannabis dispensaries. The regulations effectively impose the same THC limits as adult-use cannabis products (100 mg per package for edibles) while banning certain product types including delta-8 THC. Legal challenges from hemp businesses are ongoing in New York state courts.

North Carolina

North Carolina remains one of the most permissive hemp states, with no total THC cap and minimal restrictions on hemp-derived products. The state has become a major source for THCA flower sold nationwide, with dozens of cultivators specializing in high-THCA, low-delta-9 THC cannabis. Legislative efforts to impose restrictions have repeatedly failed, making North Carolina a critical supply source for Virginia businesses prior to the THC cap.

Ohio

Ohio banned delta-8 THC and other intoxicating hemp cannabinoids in 2023 through administrative action by the State Board of Pharmacy, which classified them as Schedule I controlled substances. Hemp industry groups filed suit, and the Ohio Supreme Court is currently reviewing whether the Board exceeded its authority. The case, *Ohio Hemp Community v. State Board of Pharmacy*, could establish important precedent on administrative agency authority over hemp.

Texas

Texas has maintained a delta-9 THC-only standard consistent with federal hemp law, despite multiple legislative attempts to impose total THC caps. The state's large hemp industry and libertarian political culture have resisted restrictions. However, the Texas Department of State Health Services issued guidance in 2023 suggesting that synthetically derived cannabinoids like delta-8 THC may not qualify as legal hemp, creating regulatory uncertainty without formal prohibition.

Market and Business Implications

Virginia's THC cap threatens to eliminate a $300-500 million hemp-derived cannabinoid market while reshaping competitive dynamics across the cannabis and hemp sectors.

Immediate Business Impacts

Retail operations face the most direct disruption. Hemp-derived THC products typically account for 60-80% of revenue at dedicated hemp and CBD stores in Virginia. A survey by the Virginia Hemp Trade Association found that 73% of member businesses expect to close or relocate if the THC cap takes effect, representing approximately 600-900 retail locations statewide. Product manufacturers and processors confront inventory obsolescence. Industry estimates suggest $50-75 million in hemp-derived THC product inventory currently in Virginia's supply chain, most of which will become unsaleable under the cap. Unlike perishable goods, cannabinoid products have extended shelf lives, meaning businesses cannot simply wait out the restriction. Testing laboratories face revenue loss from reduced compliance testing demand, though some may gain business from increased enforcement testing by VDACS. Virginia hosts approximately 15 ISO-accredited cannabis testing laboratories, several of which derive 40-60% of revenue from hemp product testing.

Supply Chain Disruption

Virginia's hemp supply chain extends nationally. Most hemp-derived THC products sold in Virginia originate from processors in Oregon, Colorado, California, and North Carolina, with raw hemp biomass sourced from farms across the country. The THC cap effectively closes Virginia as a market for these interstate suppliers, forcing them to redirect inventory to states with more permissive regulations. Conversely, Virginia hemp farmers who cultivated high-THCA flower for the smokable hemp market face demand collapse. Approximately 200-300 Virginia hemp farmers grew cannabis specifically for THCA flower production in 2025, representing roughly 2,000-3,000 acres of cultivation. These farmers must pivot to CBD-focused genetics, industrial hemp, or exit the market entirely.

Labor Market Effects

Direct employment in Virginia's hemp-derived cannabinoid sector includes an estimated 5,000-8,000 workers in retail, manufacturing, distribution, and testing. Job losses will concentrate in urban areas including Richmond, Virginia Beach, Norfolk, and Northern Virginia, where hemp retail density is highest. Ancillary employment in packaging, marketing, legal services, and real estate adds another 2,000-3,000 positions at risk. However, some employment may shift rather than disappear. Licensed cannabis dispensaries in Virginia could absorb some displaced workers as the adult-use market expands, though the timeline remains uncertain given Virginia's slow cannabis licensing rollout.

Consumer Impacts and Substitution Patterns

Virginia consumers face sharply reduced access to cannabinoid products. The state's limited medical cannabis program serves approximately 15,000 registered patients, while adult-use cannabis retail remains sparse with fewer than 20 operational dispensaries statewide as of mid-2026. Hemp-derived products filled this gap for an estimated 200,000-400,000 regular consumers. Likely substitution patterns include increased online purchasing from out-of-state retailers (though interstate shipping of intoxicating hemp products faces legal uncertainty), travel to neighboring states with more permissive hemp laws, or return to unregulated black markets. Public health researchers have expressed concern that eliminating legal, tested hemp products could drive consumers toward untested, potentially dangerous alternatives.

Tax Revenue Implications

Virginia collects sales tax on hemp products at the standard 5.3% rate (4.3% state, 1% local), generating an estimated $15-25 million annually from hemp-derived cannabinoid sales. The THC cap eliminates this revenue stream without immediate replacement, as cannabis tax revenue remains minimal given the limited adult-use market. Some revenue may eventually shift to cannabis sales taxes (currently 21% excise tax plus standard sales tax), but the transition timeline is uncertain.

Multi-State Operator Strategies

Large hemp companies with national footprints are reassessing Virginia operations. Charlotte's Web, one of the nation's largest CBD brands, has indicated it will maintain Virginia presence focused on compliant CBD products under 0.3% total THC. However, companies specializing in delta-8 THC and THCA products, including regional operators like Blue Ridge Hemp Company and Commonwealth Cannabis, face existential challenges. Some MSOs are pursuing a wait-and-see approach, maintaining minimal Virginia operations while the litigation proceeds. Others are accelerating expansion in states with more favorable hemp regulations, including North Carolina, Tennessee, and Georgia. Capital investment in Virginia hemp infrastructure has effectively frozen, with several planned processing facilities and retail expansions on indefinite hold.

What Experts Say

Legal scholars, industry analysts, and policy experts offer divergent assessments of Virginia's THC cap and its likely legal fate. Robert Mikos, a law professor at Vanderbilt University specializing in cannabis federalism, has analyzed the preemption question extensively. According to Mikos, the 2018 Farm Bill's savings clause preserving state authority creates a strong presumption in favor of state regulatory discretion, though he notes the dormant Commerce Clause argument presents Virginia's most significant legal vulnerability. Shawn Hauser, a partner at Vicente Sederberg LLP representing hemp businesses in multiple state challenges, has described total THC caps as "regulatory overreach that contradicts congressional intent in the Farm Bill." Hauser points to legislative history indicating Congress deliberately chose a delta-9 THC-only standard to create a clear, measurable distinction between hemp and marijuana. Jonathan Miller, general counsel for the U.S. Hemp Roundtable, has characterized Virginia's approach as part of a broader state backlash against intoxicating hemp products. Miller argues that appropriate regulation should focus on age restrictions, labeling, and potency limits for finished products rather than redefining hemp itself. From the public health perspective, Kevin Sabet, president of Smart Approaches to Marijuana, has supported Virginia's THC cap as necessary to prevent proliferation of unregulated intoxicating products. According to Sabet, the hemp industry exploited a loophole in the Farm Bill that Congress never intended to create a parallel marijuana market. Steven Hoffman, a cannabis industry analyst at Viridian Capital Advisors, has noted that state-level hemp restrictions create opportunities for licensed cannabis operators by eliminating competition. Hoffman estimates that total THC caps across multiple states could redirect $500 million to $1 billion in annual consumer spending from hemp to regulated cannabis markets. Dale Hunt, director of the Virginia Hemp Coalition, has described the THC cap as economically devastating for small businesses that invested heavily in hemp retail and manufacturing based on the regulatory environment established after the 2018 Farm Bill. Hunt emphasizes that many hemp businesses are minority-owned and operate in communities underserved by licensed cannabis retailers.

What's Next

The Virginia hemp THC cap faces a multi-stage legal and political process that will unfold over 12-24 months, with implications extending far beyond the commonwealth.

Immediate Legal Timeline

The U.S. District Court for the Eastern District of Virginia has scheduled a preliminary injunction hearing for September 15, 2026. Plaintiffs must demonstrate likelihood of success on the merits, irreparable harm, balance of equities favoring an injunction, and public interest supporting preliminary relief. Judge Anthony Trenga, a George W. Bush appointee with a background in regulatory law, will preside. If the court grants a preliminary injunction, the THC cap would be blocked pending full trial on the merits, likely preserving the status quo for 12-18 months. If the court denies the injunction, the cap takes effect on July 1, 2026, forcing immediate business decisions about compliance, inventory liquidation, or closure. Regardless of the preliminary injunction outcome, full litigation will proceed through discovery, summary judgment motions, and potentially trial. The timeline for final resolution typically extends 18-36 months from filing, meaning definitive legal clarity may not arrive until 2028.

Appellate Trajectory

The losing party will almost certainly appeal to the U.S. Court of Appeals for the Fourth Circuit, which has jurisdiction over Virginia. The Fourth Circuit has limited cannabis-specific precedent, making prediction difficult. Further appeal to the U.S. Supreme Court remains possible, particularly if circuit courts split on similar hemp THC cap challenges in other states. A Supreme Court case could definitively resolve the scope of state authority under the 2018 Farm Bill's savings clause—a question with national implications for hemp regulation. However, the Court accepts only a small fraction of petitions, and resolution at that level could take 3-5 years from initial filing.

Legislative Scenarios

Virginia's General Assembly could modify the THC cap during the 2027 legislative session, particularly if preliminary litigation outcomes suggest legal vulnerability. Potential amendments include raising the total THC threshold to 1-2%, creating a separate regulatory framework for hemp-derived cannabinoid products similar to California's approach, or implementing per-serving limits rather than concentration caps. Industry advocates are already organizing for the 2027 session, with draft legislation proposing a regulated hemp cannabinoid market with age restrictions, testing requirements, and potency limits but without the 0.3% total THC cap. Success depends on political dynamics and whether litigation creates pressure for compromise.

Federal Developments

Congress may address the hemp THC issue through Farm Bill reauthorization, currently scheduled for 2028. Draft proposals circulating in agricultural committees include options to clarify that the 0.3% threshold applies only to delta-9 THC, to establish federal standards for hemp-derived cannabinoid products, or to grant the FDA explicit authority over intoxicating hemp products. The FDA has signaled interest in regulating hemp-derived cannabinoid products but faces resource constraints and competing priorities. The agency issued a statement in May 2026 indicating it is developing a regulatory framework for CBD and other hemp cannabinoids, but provided no timeline for proposed rules. The DEA has maintained that synthetically derived THC isomers like delta-8 THC may be controlled substances under the Federal Analogue Act, creating additional legal uncertainty. However, the agency has not pursued enforcement actions against hemp businesses, focusing resources on traditional marijuana and opioid cases.

Market Evolution

Regardless of litigation outcomes, the hemp-derived cannabinoid market is evolving toward greater regulation. Industry leaders anticipate a future landscape with clear federal standards, state-level licensing requirements similar to alcohol, and product categories differentiated by potency and intended use. Some analysts predict consolidation, with larger, well-capitalized companies better positioned to navigate complex compliance requirements while smaller operators exit or are acquired. Others foresee continued state-by-state fragmentation, with businesses specializing in particular regulatory environments and limiting geographic scope.

Further Reading

• Agricultural Improvement Act of 2018 (2018 Farm Bill), Public Law 115-334, full text available at https://www.congress.gov/bill/115th-congress/house-bill/2
• Virginia Code § 3.2-4112 et seq. (Hemp Program), available at https://law.lis.virginia.gov/vacode/title3.2/chapter41/
• Virginia Senate Bill 903 (2025), full text and legislative history at https://lis.virginia.gov/cgi-bin/legp604.exe?251+sum+SB903
• USDA Hemp Production Program regulations, 7 CFR Part 990, available at https://www.federalregister.gov/documents/2021/01/19/2021-00967/establishment-of-a-domestic-hemp-production-program
• U.S. Hemp Roundtable policy resources and state tracking at https://www.hempsupporter.com/
• Virginia Department of Agriculture and Consumer Services hemp program information at https://www.vdacs.virginia.gov/plant-industry-services-hemp.shtml
• National Conference of State Legislatures hemp state laws database at https://www.ncsl.org/agriculture-and-rural-development/state-industrial-hemp-statutes
• FDA statement on cannabinoid products (May 2026) at https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products
• Viridian Capital Advisors cannabis and hemp market reports at https://www.viridianca.com/research
• Congressional Research Service report "The 2018 Farm Bill: Hemp Production and the Federal-State Regulatory Framework" at https://crsreports.congress.gov/